Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review
Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review
BACKGROUND: Eczema, synonymous with atopic eczema or atopic dermatitis, is a chronic skin disease that has a similar impact on health-related quality of life as other chronic diseases. The proposed research aims to provide a comprehensive systematic assessment of the economic evidence base available to inform economic modelling and decision making on interventions to prevent and treat eczema at any stage of the life course. Whilst the Global Resource of Eczema Trials (GREAT) database collects together the effectiveness evidence for eczema, there is currently no such systematic resource on the economics of eczema. It is important to gain an overview of the current state of the art of economic methods in the field of eczema in order to strengthen the economic evidence base further.
METHODS/DESIGN: The proposed study is a systematic review of the economic evidence surrounding interventions for the prevention and treatment of eczema. Relevant search terms will be used to search MEDLINE, EMBASE, Database of Abstracts of Reviews of Effects, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, National Health Service (NHS) Economic Evaluation Database, Health Technology Assessment, Cumulative Index to Nursing and Allied Health Literature, EconLit, Scopus, Cost-Effectiveness Analysis Registry and Web of Science in order to identify relevant evidence. To be eligible for inclusion studies will be primary empirical studies evaluating the cost, utility or full economic evaluation of interventions for preventing or treating eczema. Two reviewers will independently assess studies for eligibility and perform data abstraction. Evidence tables will be produced presenting details of study characteristics, costing methods, outcome methods and quality assessment. The methodological quality of studies will be assessed using accepted checklists.
DISCUSSION: The systematic review is being undertaken to identify the type of economic evidence available, summarise the results of the available economic evidence and critically appraise the quality of economic evidence currently available to inform future economic modelling and resource allocation decisions about interventions to prevent or treat eczema. We aim to use the review to offer guidance about how to gather economic evidence in studies of eczema and/or what further research is necessary in order to inform this.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42015024633.
Cost-Benefit Analysis, Decision Making, Dermatitis, Atopic/economics, Evidence-Based Medicine, Health Status, Humans, Models, Economic, Quality of Life, Quality-Adjusted Life Years, Systematic Reviews as Topic
90
Sach, Tracey Helen
5c09256f-ebed-4d14-853a-181f6c92d6f2
McManus, Emma
f04f4622-5b27-41f6-ae69-c4a24b9b87f5
Mcmonagle, Christopher
f6426bd7-8527-4669-a8ce-fae629803d00
Levell, Nick
f101760e-bf8e-457b-a730-95a7d1b39067
27 May 2016
Sach, Tracey Helen
5c09256f-ebed-4d14-853a-181f6c92d6f2
McManus, Emma
f04f4622-5b27-41f6-ae69-c4a24b9b87f5
Mcmonagle, Christopher
f6426bd7-8527-4669-a8ce-fae629803d00
Levell, Nick
f101760e-bf8e-457b-a730-95a7d1b39067
Sach, Tracey Helen, McManus, Emma, Mcmonagle, Christopher and Levell, Nick
(2016)
Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review.
Systematic Reviews, 5, .
(doi:10.1186/s13643-016-0262-0).
Abstract
BACKGROUND: Eczema, synonymous with atopic eczema or atopic dermatitis, is a chronic skin disease that has a similar impact on health-related quality of life as other chronic diseases. The proposed research aims to provide a comprehensive systematic assessment of the economic evidence base available to inform economic modelling and decision making on interventions to prevent and treat eczema at any stage of the life course. Whilst the Global Resource of Eczema Trials (GREAT) database collects together the effectiveness evidence for eczema, there is currently no such systematic resource on the economics of eczema. It is important to gain an overview of the current state of the art of economic methods in the field of eczema in order to strengthen the economic evidence base further.
METHODS/DESIGN: The proposed study is a systematic review of the economic evidence surrounding interventions for the prevention and treatment of eczema. Relevant search terms will be used to search MEDLINE, EMBASE, Database of Abstracts of Reviews of Effects, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, National Health Service (NHS) Economic Evaluation Database, Health Technology Assessment, Cumulative Index to Nursing and Allied Health Literature, EconLit, Scopus, Cost-Effectiveness Analysis Registry and Web of Science in order to identify relevant evidence. To be eligible for inclusion studies will be primary empirical studies evaluating the cost, utility or full economic evaluation of interventions for preventing or treating eczema. Two reviewers will independently assess studies for eligibility and perform data abstraction. Evidence tables will be produced presenting details of study characteristics, costing methods, outcome methods and quality assessment. The methodological quality of studies will be assessed using accepted checklists.
DISCUSSION: The systematic review is being undertaken to identify the type of economic evidence available, summarise the results of the available economic evidence and critically appraise the quality of economic evidence currently available to inform future economic modelling and resource allocation decisions about interventions to prevent or treat eczema. We aim to use the review to offer guidance about how to gather economic evidence in studies of eczema and/or what further research is necessary in order to inform this.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42015024633.
This record has no associated files available for download.
More information
Published date: 27 May 2016
Keywords:
Cost-Benefit Analysis, Decision Making, Dermatitis, Atopic/economics, Evidence-Based Medicine, Health Status, Humans, Models, Economic, Quality of Life, Quality-Adjusted Life Years, Systematic Reviews as Topic
Identifiers
Local EPrints ID: 480806
URI: http://eprints.soton.ac.uk/id/eprint/480806
ISSN: 2046-4053
PURE UUID: b2ddc892-49c4-4f5e-a7a6-1a267ec466cb
Catalogue record
Date deposited: 09 Aug 2023 17:14
Last modified: 17 Mar 2024 04:20
Export record
Altmetrics
Contributors
Author:
Tracey Helen Sach
Author:
Emma McManus
Author:
Christopher Mcmonagle
Author:
Nick Levell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics